Similar to their results, in this current research, we found that TRIP can mediate TAK1 K48-linked polyubiquitination and promote TAK1 degradation, leading to the inhibition of TNFα-induced NF-κB activation in RA-FLS. The gene discussed is TRAIP; the disease is rheumatoid arthritis.